KolmarBNH Co Ltd
KOSDAQ:200130
Net Margin
KolmarBNH Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| KR |
K
|
KolmarBNH Co Ltd
KOSDAQ:200130
|
400.9B KRW |
3%
|
|
| FR |
|
L'Oreal SA
PAR:OR
|
199.3B EUR |
15%
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
116.3B GBP |
9%
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.5T INR |
17%
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
37.3B GBP |
13%
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
26.9B EUR |
9%
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
22.9B USD |
-6%
|
|
| JP |
|
Kao Corp
TSE:4452
|
2.9T JPY |
7%
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.3T INR |
13%
|
|
| CN |
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
78.9B HKD |
37%
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
854.2B INR |
14%
|
KolmarBNH Co Ltd
Glance View
KolmarBNH Co., Ltd. engages in the provision of manufacturing medicaments. The company is headquartered in Sejong, Sejong. The company went IPO on 2014-07-23. The firm mainly produces health functional foods to improve immunity, such as atomy hemohims and others. The firm also produces cosmetics using natural extracts, and other pharmaceuticals. The firm also engages in research, development and manufacture of cosmetic functional materials which belongs to phytochemical business that mainly uses natural extracts as cosmetic materials.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on KolmarBNH Co Ltd's most recent financial statements, the company has Net Margin of 2.9%.
You don't have any saved screeners yet